David Holder currently serves as the Managing General Partner for Holder Capital Partners, a Southern California focused, early stage, consulting practice, accelerating healthcare companies in the delivery/services, healthcare information technologies, devices and diagnostics segments. Since 1980 David Holder has worked with and invested in nine early stage healthcare ventures and on average returned 6.9 times the invested capital for each deal. Each investment had an average life cycle of 43 months. In addition to it’s limited partner investments with Mission Ventures (outlined below) Holder Capital Partners has two current portfolio investments with one projecting liquidity in 2007 (currently valued at 7 times the invested capital).
From 1996 through 2001, Mr. Holder was a Founding Venture Partner at Mission Ventures where he helped raise its initial $63 million fund. During his tenure at Mission, a total of $288 million was raised in two funds. He continues to serve as the Healthcare Consultant to the Mission Ventures Partnership, having brought all five of the current healthcare investments of Mission to the partnership. David Holder will continue to serve as consultant to MV through 2006. In that capacity he represents Mission as an observer on two current boards and as a board member on another. David Holder will spend substantially all of his time on the business of HCP in addition to his obligations to MV.
Prior to Mission Ventures, Mr. Holder was instrumental in the founding and/or early stage development and funding of more than ten companies including Pyxis, acquired for $986 million by Cardinal Health; TheraTx, acquired for $680 million by Vencor (now known as Kindred Healthcare); Caremark, originally acquired for $575 million by Baxter and later by MedPartners; Pancretec, acquired for $58 million by Abbott; and EDiX, acquired for $30 million by IDX Corporation and later by Total eMed for $64 million. In 1995, Pyxis and TheraTx ranked number one and number two, respectively, on the “Inc. Magazine” list of the 100 fastest growing public companies. The approximate current market value of these investments far exceeds $5.8 billion.
Mr. Holder’s background also includes staff and line management responsibilities with two divisions of Baxter Laboratories, and as Director of Sales for the McGaw division of American Hospital Supply Corp. In addition, he held VP and General Management positions at Bergen Brunswig Medical (now AmerisourceBergen) and Caremark.